Impact of a community pharmacy based information program on type 2 diabetic patients' adherence to their oral treatment

Not Applicable

Completed

• Conditions: Diabetes; Nutritional, Metabolic, Endocrine; Diabetes mellitus

• Registration Number: ISRCTN33776525
• Lead Sponsor: Observia

Brief Summary

2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31049873 (added 01/05/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-12-31
• Study Start: 2017-04-25
• Last Update Posted: 11 May 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

1. Men or women
2. Age >18 years
3. Diabetics with less four oral antidiabetics medications
4. HbA1c> 6.7%
5. Patient present at pharmacy for more than 6 months

Exclusion Criteria

1. Cancer
2. Patients with insulin treatment or anti-diabetics injectables

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medication Possession Ratio (MPR), measured by the pharmacist by counting tablets remaining in the treatment packs delivered to the patient during the previous visit, at 6 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. HbA1c level, measured by laboratory analysis at 6 months<br> 2. Adherence, measured by a specific questionnaire (TOP) at 6 months<br> 3. Patient’s knowledge acquisition, measured by a specific questionnaire developed by the scientific committee at 6 months<br> 4. Patient’s satisfaction, measured by a specific questionnaire developed by the scientific committee, for the patients in group A at 6 months<br>